MAHON PAUL A sold UTHR

March 5, 2026 · Form 4 insider transaction

MAHON PAUL A sold 743 shares of United Therapeutics Corporation at $486.52 per share, a transaction worth $361.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
743
Price
$486.52
Total value
$361.5K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 5, 2026
Filing dateMarch 5, 2026
Shares owned after37,044
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025.; This transaction was executed in multiple trades at prices ranging from $486.41 to $486.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR
MAHON PAUL A sold UTHR: March 5, 2026 | Insider Trading Screener